Go Pro

HC Wainwright's Rating of Portage Biotech on 8/17/2026

On August 17, 2026, HC Wainwright updated its outlook on Portage Biotech (NASDAQ:ALP) with the action "Initiated Coverage", setting a "Neutral" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
8/18/2026
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
Reiterated Rating
8/18/2026
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
Reiterated Rating
8/18/2026
Invivyd, Inc. stock logo
IVVD
Invivyd
Reiterated Rating
8/18/2026
Pioneer Power Solutions, Inc. stock logo
PPSI
Pioneer Power Solutions
Reiterated Rating
8/18/2026
Perpetua Resources Corp. stock logo
PPTA
Perpetua Resources
Reiterated Rating
8/18/2026
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
Reiterated Rating
More Ratings From HC Wainwright